Levels of High-Sensitivity C-Reactive Protein in Heart Transplant Patients (NCT03671408) | Clinical Trial Compass
CompletedNot Applicable
Levels of High-Sensitivity C-Reactive Protein in Heart Transplant Patients
33 participantsStarted 2016-04-20
Plain-language summary
Inflammation plays a key role in the deterioration of chronic heart transplants. Periodontal disease is not limited to the tooth-supporting structures - it also contributes to systemic inflammation. This study explored whether periodontitis is associated with serum high-sensitivity C-reactive protein (hs-CRP) levels in heart transplant patients.
The study included 33 patients who had undergone heart transplantation at Baskent University Hospital. Clinical periodontal parameters were recorded, and blood samples were collected on the same day to measure serum hs-CRP.
Who can participate
Age range
11 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Patients who underwent heart transplant procedures at Baskent University Hospital
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This study looked at high-sensitivity C-reactive protein (hs-CRP) levels in heart transplant patients with periodontitis — has my own hs-CRP been checked, and what would an elevated result mean for my care after transplant?
2Since this trial studied the link between gum disease and inflammation markers in heart transplant recipients, should I be seeing a dentist regularly as part of my post-transplant monitoring routine?
3This was an observational study rather than a treatment trial — are there any follow-up studies based on these findings that might actually test whether treating periodontitis helps improve outcomes for heart transplant patients?
4The study focused on hs-CRP as a marker of inflammation — how does my care team currently use inflammation markers like hs-CRP to track rejection risk or overall health after a heart transplant?
5Given that this research is now completed, has my transplant team seen or discussed its findings, and do those results change any recommendations about dental care or inflammation monitoring for someone in my situation?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.